Related references
Note: Only part of the references are listed.PEGylated NaHoF4 nanoparticles as contrast agents for both X-ray computed tomography and ultra-high field magnetic resonance imaging
Dalong Ni et al.
BIOMATERIALS (2016)
PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer
Jun Xin et al.
EUROPEAN JOURNAL OF RADIOLOGY (2016)
Clinical application of PET/MRI in oncology
Houman Sotoudeh et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2016)
Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives
Yufei Ma et al.
SMALL (2016)
Development of Radiolabeled Molecular Imaging Probes for in Vivo Analysis of Biological Function
Masashi Ueda
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2016)
Versatile Nanosystem-Based Cancer Theranostics: Design Inspiration and Predetermined Routing
Yaw Opoku-Damoah et al.
THERANOSTICS (2016)
Progress in the Development of Nanotheranostic Systems Honggang
Honggang Cui et al.
THERANOSTICS (2016)
Synthesis, characterization, and biodistribution studies of 99mTc-labeled SBA-16 mesoporous silica nanoparticles
Andre Luis Branco de Barros et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2015)
Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery
Rubel Chakravarty et al.
NANOMEDICINE (2015)
Synthesis of heterodimer radionuclide nanoparticles for magnetic resonance and single-photon emission computed tomography dual-modality imaging
Jing Zhu et al.
NANOSCALE (2015)
Dual-Targeting Upconversion Nanoprobes across the Blood-Brain Barrier for Magnetic Resonance/Fluorescence Imaging of Intracranial Glioblastoma
Dalong Ni et al.
ACS NANO (2014)
Magnetically Decorated Multiwalled Carbon Nanotubes as Dual MRI and SPECT Contrast Agents
Julie Tzu-Wen Wang et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Break-up of Two-Dimensional MnO2 Nanosheets Promotes Ultrasensitive pH-Triggered Theranostics of Cancer
Yu Chen et al.
ADVANCED MATERIALS (2014)
RGD-targeted MnO nanoparticles as T1 contrast agents for cancer imaging - the effect of PEG length in vivo
Juan Gallo et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radio labeled Mesoporous Silica Nanoparticles
Feng Chen et al.
ACS NANO (2013)
Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging
J. Xiao et al.
SCIENTIFIC REPORTS (2013)
Kit formulation for 99mTc-labeling of HYNIC-βAla-Bombesin(7-14)
Andre Luis Branco de Barros et al.
APPLIED RADIATION AND ISOTOPES (2012)
Structure-property relationships in manganese oxide - nnesoporous silica nanoparticles used for T1-weighted MRI and simultaneous anti-cancer drug delivery
Yu Chen et al.
BIOMATERIALS (2012)
Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells
Yu Chen et al.
BIOMATERIALS (2012)
Nanoprobes for hybrid SPECT/MR molecular imaging
Ripen Misri et al.
NANOMEDICINE (2012)
Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe
Ripen Misri et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
A SPECT camera for combined MRI and SPECT for small animals
D. Meier et al.
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT (2011)
Inorganic Nanoparticles for MRI Contrast Agents
Hyon Bin Na et al.
ADVANCED MATERIALS (2009)
A Novel Type of Dual-Modality Molecular Probe for MR and Nuclear Imaging of Tumor: Preparation, Characterization and in Vivo Application
Shujie Liu et al.
MOLECULAR PHARMACEUTICS (2009)
Nephrogenic Systemic Fibrosis: Incidence, Associations, and Effect of Risk Factor Assessment-Report of 33 Cases
Javier Perez-Rodriguez et al.
RADIOLOGY (2009)
What nephrologists need to know about gadolinium
Jeffrey G. Penfield et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors
PA Schornack et al.
NEOPLASIA (2003)